Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 9/20 | 0.53 |
| ▸ | ABCB1 | P08183 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.51 |
| ▸ | RELA | Q04206 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | AHR | P35869 | 1/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.50 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.50 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.49 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.47 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.47 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.46 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.46 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21257294 | 0.98 | ABCG2 (0.54) | ABCG2ABCB1ALDH1A1MAPK1NPC1 | |
| SCHEMBL23594522 | 0.92 | ABCG2 (0.50) | ABCG2ABCB1ALDH1A1MAPK1NPC1 | |
| SCHEMBL22360641 | 0.91 | ABCG2 (0.60) | ABCG2ABCB1ABCC1ALDH1A3GABRA1 | |
| SCHEMBL23384091 | 0.91 | ABCG2 (0.60) | ABCG2ABCB1ABCC1ALDH1A3GABRA1 | |
| SCHEMBL22883053 | 0.91 | ABCG2 (0.60) | ABCG2ABCB1ABCC1ALDH1A3GABRA1 | |
| SCHEMBL23383904 | 0.91 | ABCG2 (0.60) | ABCG2ABCB1ABCC1ALDH1A3GABRA1 | |
| SCHEMBL23383850 | 0.91 | ABCG2 (0.60) | ABCG2ABCB1ABCC1ALDH1A3GABRA1 | |
| SCHEMBL22106575 | 0.91 | ABCG2 (0.60) | ABCG2ABCB1ABCC1ALDH1A3GABRA1 | |
| SCHEMBL20396079 | 0.91 | ABCG2 (0.60) | ABCG2ABCB1ABCC1ALDH1A3GABRA1 | |
| SCHEMBL20385208 | 0.91 | AHR (0.57) | ABCG2ABCB1ALDH1A1SMN1; SMN2AHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11678576-B2 | Heterocyclic compound and organic light emitting element comprising same | LT MATERIALS CO., LTD. (KR) | 2023-06-13 | — | — | US | disclosed |
| US-11678576-B2 | Heterocyclic compound and organic light emitting element comprising same | LT MATERIALS CO., LTD. (KR) | 2023-06-13 | — | — | US | disclosed |
| EP-3858831-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LT Materials Co., Ltd. (KR) | 2021-08-04 | — | — | EP | disclosed |
| US-20210202863-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LT MATERIALS CO., LTD. (KR) | 2021-07-01 | — | — | US | disclosed |
| WO-2020067594-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | 희성소재(주) | 2020-04-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210202863-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, CYP1A1 | ABCG2 2475/4885ABCB1 1530/4885ALDH1A1 15/4885 |
| US-11678576-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, CYP1A1 | ABCG2 2475/4885ABCB1 1530/4885ALDH1A1 15/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.